A randomized controlled trial for Jiuwei Zhuhuang powder in the treatment of infantile cough
- Conditions
- cough
- Registration Number
- ITMCTR2100004840
- Lead Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. The patient was diagnosed as a child with acute upper respiratory tract infection, and cough was the main symptom (>=2 points), and the onset time was within 48h;
2. syndrome differentiation for Tibetan medicine qiang cai;
3. Aged 2 to 14 years.
1. Children with severe malnutrition, or accompanied by other serious systemic diseases such as cardiovascular, liver, kidney and hematopoietic system, children with mental disorders, and children allergic to this medicine;
2. Children with epstein-barrvirus (EBV) infection, mycoplasma infection, high risk of upper respiratory tract diseases and respiratory infectious diseases;
3. Children with bronchiolitis, bronchitis, pneumonia and other lower respiratory tract infections;
4. Children who have taken anti-cold or cough medicine (including western medicine and traditional Chinese medicine) after onset.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough;
- Secondary Outcome Measures
Name Time Method asal congestion;Runny nose;Sneeze;Body temperature;adverse reactions;